- Home
- JANX vs CLB Comparison
JANX vs CLB Comparison
Compare JANX & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | CLB |
|---|---|---|
| Founded | 2017 | 1936 |
| Country | United States | United States |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 864.2M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | JANX | CLB |
|---|---|---|
| Price | $15.18 | $16.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $50.09 | $12.50 |
| AVG Volume (30 Days) | ★ 929.9K | 329.2K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.63 |
| Revenue | $10,000,000.00 | ★ $526,520,000.00 |
| Revenue This Year | N/A | $3.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.14 |
| Revenue Growth | N/A | ★ 0.51 |
| 52 Week Low | $12.12 | $9.72 |
| 52 Week High | $35.34 | $20.36 |
Technical Indicators
Market Signals| Indicator | JANX | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 51.46 |
| Support Level | $13.10 | $15.66 |
| Resistance Level | $15.49 | $17.05 |
| Average True Range (ATR) | 0.57 | 0.74 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 86.29 | 46.84 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.